GFAP and Machado-Joseph disease: As a result, no significant difference was detected in the GFAP signal intensity level between exosomal miRNA treated SCA3 mice and control SCA3 mice, though the Control-Wt group showed a lower GFAP staining level (p < 0.05) (Fig. 5).